Trial in Adult Participants With Spinocerebellar Ataxia (SCA)
Completed · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2, Spinocerebellar Ataxia Genotype Type 3, Spinocerebellar Ataxia Genotype Type 6, Spinocerebellar Ataxia Genotype Type 7, Spinocerebellar Ataxia Genotype Type 8, Spinocerebellar Ataxia Genotype Type 10
In brief
The primary purpose of this study was to compare the efficacy of BHV-4157 (Troriluzole) 140 milligrams (mg) once daily versus placebo after 8 weeks of treatment in participants with spinocerebellar ataxia (SCA).
Key facts
- Study ID
- NCT02960893
- Run by
- Biohaven Pharmaceuticals, Inc.
- People needed
- 141
- Starts
- 2016-12-15
- Expected to finish
- 2024-09-20
- Last updated by the study team
- 2025-10-08
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- CNS Trial — Long Beach, California, United States
- University of California, Los Angeles — Los Angeles, California, United States
- University of California, San Francisco — San Francisco, California, United States
- University of Colorado Denver — Denver, Colorado, United States
- University of Florida — Gainesville, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Northwestern University — Chicago, Illinois, United States
- University of Chicago — Chicago, Illinois, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Harvard University (Massachusetts General Hospital) — Boston, Massachusetts, United States
- Harvard University (Beth Israel Deaconess Medical Center) — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Columbia University — New York, New York, United States
- University of Rochester Medical Center — Rochester, New York, United States
- University of Texas Southwestern — Dallas, Texas, United States
- Houston Methodist Research Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.